Medifast Inc
MED
Market Cap$281.31M
Close$
$41.67
62% upside
Current Fair Value
62% upsideUndervalued by 62% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $281.31 Million |
|---|---|
| Enterprise Value | $183.83 Million |
| Dividend Yield | $3.2665 (12.7%) |
| Earnings per Share | $6.2 |
| Beta | 1.11 |
| Outstanding Shares | 10,937,245 |
| Avg 30 Day Volume | 498,041 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 4.15 |
|---|---|
| PEG | -5.24 |
| Price to Sales | 0.31 |
| Price to Book Ratio | 1.35 |
| Enterprise Value to Revenue | 0.2 |
| Enterprise Value to EBIT | 2.27 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Medifast Inc
550 employees
CEO: Daniel Chard Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and ...